HIGHLIGHTS
- who: Against Epilepsy and collaborators from the Department of Pharmacy, India have published the research work: Therapeutic Perspectives of Brivaracetam Against Epilepsy, in the Journal: (JOURNAL) of July/01,/2022
- future: Future Directions Pharmacokinetics Brivaracetam bioavailability is quick and nearly complete after oral dosing.
SUMMARY
Received: Abbreviations: FDA: Food and Drug Administration; GAERS: Genetic Absence Epilepsy Rat from Strasbourg; AEDs: Anti-Epileptic Medications Published: July 06, 2022 Perspective Seizure is the fourth leading neuro disease affect about 85 million people worldwide. The symptoms of seizures are due to an aberrant synchronized . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.